BRIEF published on 10/10/2025 at 18:35, 10 months 4 days ago Publication mensuelle des droits de vote de Theraclion Investissement Droits De Vote Capital Social Euronext Growth Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 10 months 4 days ago Inside Information / Other news releases Theraclion provides monthly update on total voting rights and shares. The French MedTech company uses focused ultrasound for non-invasive treatment. CE-marked platform SONOVEIN® targets varicose veins Voting Rights Shares Theraclion SONOVEIN Focused Ultrasound
PRESS RELEASE published on 10/10/2025 at 18:30, 10 months 4 days ago Informations privilégiées / Autres communiqués Communiqué mensuel sur les droits de vote et actions de Theraclion, société française de MedTech. Détails des actions en circulation et droits de vote réels Euronext PEA PME MedTech France Theraclion
BRIEF published on 09/15/2025 at 18:35, 10 months 29 days ago Theraclion Successfully Completes Pivotal Study with 96.8% Occlusion Rate FDA Clinical Trial Theraclion SONOVEIN® Varicose Veins
BRIEF published on 09/15/2025 at 18:35, 10 months 29 days ago Theraclion Réussit son Étude Pivotal avec un Taux d'Occlusion de 96,8 % FDA Essai Clinique Theraclion SONOVEIN® Varices
PRESS RELEASE published on 09/15/2025 at 18:30, 10 months 29 days ago Informations privilégiées / Autres communiqués Theraclion annonce le succès de son étude pivotale américaine FDA avec un taux d'occlusion de 96,8% pour Sonovein®, sa plateforme de traitement des varices par ultrasons focalisés de haute intensité FDA Theraclion SONOVEIN Étude Pivotale Occlusion
PRESS RELEASE published on 09/15/2025 at 18:30, 10 months 29 days ago Inside Information / Other news releases Theraclion announces successful U.S. FDA pivotal study showing 96.8% occlusion rate with Sonovein® for varicose vein treatment. Results support potential U.S. market entry Theraclion SONOVEIN® U.S. FDA Study Varicose Vein Treatment Occlusion Rate
BRIEF published on 07/25/2025 at 18:35, 1 year ago Theraclion in full expansion in the first half of 2025 Financial Results Clinical Trials Business Expansion Theraclion SONOVEIN
BRIEF published on 07/25/2025 at 18:35, 1 year ago Theraclion en pleine expansion au premier semestre 2025 Résultats Financiers Essais Cliniques Expansion Commerciale Theraclion SONOVEIN
PRESS RELEASE published on 07/25/2025 at 18:30, 1 year ago Inside Information / News release on accounts, results Theraclion reports strong growth in S1 2025 with increased revenue and expansion into new markets. Key achievements include 30% rise in consumables sales and completion of pivotal FDA clinical trial follow-up period Revenue Growth Business Expansion Theraclion FDA Clinical Trial S1 2025
Published on 08/15/2026 at 00:50, 10 hours 30 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 11 hours 5 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 11 hours 35 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 11 hours 55 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 12 hours 20 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 3 hours 15 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 17 hours 5 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 19 hours 15 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 17 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 17 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 17 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 17 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
